Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

UTI Nifty Bank ETF · Direct ✕Nippon India Nifty Pharma ETF · Direct ✕

Growth of ₹10,000

Basics

UTI Nifty Bank ETFNippon India Nifty Pharma ETF
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseUTINippon India
NAV₹66.9307₹29.1863
NAV date20 Nov 202620 Nov 2026
History6.2 years5.4 years
Expense ratio0.0%0.2%
StarsNot ratedNot rated
Growth Score——

Returns

UTI Nifty Bank ETFNippon India Nifty Pharma ETF
1 month+16.47%+10.82%
3 months+12.37%+7.43%
6 months+21.13%+14.54%
YTD+8.98%+25.40%
1 year+9.37%+25.57%
3 years (CAGR)+14.73%+22.02%
5 years (CAGR)+11.94%+16.60%
10 years (CAGR)——
Since launch+18.31%+14.02%

Risk

UTI Nifty Bank ETFNippon India Nifty Pharma ETF
Volatility19.5%15.0%
Downside volatility12.2%9.0%
Sharpe0.421.04
Sortino0.671.72
Calmar0.801.33
Return / risk0.761.47
Deepest fall−20.59%−20.98%
Days to recover90136
Below its high+0.00%−1.75%

Against benchmark

UTI Nifty Bank ETFNippon India Nifty Pharma ETF
Alpha+0.04%+0.00%
Beta1.001.00
R²100.0%100.0%
Up capture100.1%100.0%
Down capture99.9%100.0%
Tracking error0.0%0.0%
Information ratio2.16—
Treynor0.070.14

Consistency

UTI Nifty Bank ETFNippon India Nifty Pharma ETF
Best 1-year+85.31%+65.21%
Middle 1-year+12.13%+13.46%
Worst 1-year−6.73%−15.30%
1-year periods with a loss7.1%25.8%
Middle 3-year+12.74%+20.51%
Positive months58.3%61.1%
Best day+5.67%+3.64%
Worst day−7.91%−4.03%
Worst 5% day−1.44%−1.62%
Positive days53.0%54.4%
NAVs a year248248

SIP of ₹10,000 a month

UTI Nifty Bank ETFNippon India Nifty Pharma ETF
5-year XIRR+13.56%+20.60%
5-year value₹8,48,646₹10,11,738
3-year XIRR+14.10%+19.58%
1-year XIRR+24.34%+34.31%

Holdings overlap i

UTI Nifty Bank ETFNippon India Nifty Pharma ETF
UTI Nifty Bank ETF—0%
Nippon India Nifty Pharma ETF0%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Sectors and company size

UTI Nifty Bank ETFNippon India Nifty Pharma ETF
Large companies78.0%45.3%
Mid companies22.0%47.1%
Small companies—7.6%
Top 10 holdings87.9%78.6%
Largest sectorBanks 100%Pharmaceuticals & Biotechnology 100%

Search Growth